Tricyclic antidepressants
**Question:** Tricyclic antidepressants
**Core Concept:** Tricyclic antidepressants (TCAs) are a class of medications primarily used to treat major depressive disorder, anxiety disorders, and some neuropathic pain conditions. They were the first line of antidepressants before the advent of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs).
**Why the Correct Answer is Right:** Amitriptyline (TCA) works by inhibiting the reuptake of neurotransmitters like norepinephrine, serotonin, and dopamine, leading to increased neurotransmitter levels in the synaptic cleft. This results in improved mood and decreased anxiety in patients with depression and anxiety disorders.
**Why Each Wrong Option is Incorrect:**
A. **Option A (Nortriptyline):** Nortriptyline is another TCA with similar pharmacological actions to amitriptyline but may have different side effect profiles, drug interactions, and therapeutic effects due to structural differences.
B. **Option B (Buspirone):** Buspirone is a serotonin-specific 5-HT1A receptor partial agonist, not an antidepressant, and is used for anxiety disorders.
C. **Option C (Mirtazapine):** Mirtazapine is a selective serotonin and norepinephrine reuptake inhibitor (SNRIs) and is not a TCA.
D. **Option D (Fluoxetine):** Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) and is not a TCA.
**Clinical Pearl:** Tricyclic antidepressants have a wider therapeutic index, meaning they have a greater margin of safety in terms of drug interactions and side effects compared to SSRIs and SNRIs. However, they are more likely to cause side effects such as dry mouth, blurred vision, and orthostatic hypotension.
**Correct Answer:** Amitriptyline (TCA)
Amitriptyline is a tricyclic antidepressant that works by inhibiting the reuptake of neurotransmitters like norepinephrine, serotonin, and dopamine, leading to increased neurotransmitter levels in the synaptic cleft. This results in improved mood and decreased anxiety in patients with depression and anxiety disorders.
Tricyclic antidepressants have a broader spectrum of action compared to selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). They have a greater therapeutic index, meaning they have a wider safety margin in terms of drug interactions and side effects compared to SSRIs and SNRIs. However, they are more likely to cause side effects such as dry mouth, blurred vision, and orthostatic hypotension.
**Why Tricyclic Antidepressants are used despite their side effects:**
1. Tricyclic antidepressants have